Evidence map›Paper›PMID 34252106›Full record

ArticlePLoS neglected tropical diseases2021

Effectiveness of Wolbachia-infected mosquito deployments in reducing the incidence of dengue and other Aedes-borne diseases in Niterói, Brazil: A quasi-experimental study.

Sofia B Pinto, Thais I S Riback, Gabriel Sylvestre, Guilherme Costa, Julia Peixoto, Fernando B S Dias, Stephanie K Tanamas, Cameron P Simmons, Suzanne M Dufault, Peter A Ryan and 11 more

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in PLoS neglected tropical diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 146 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed, 1 pooled it
29.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 1 synthesis or guideline pooled it, 225 citations in OpenAlex.

  1. Wolbachia-carrying Aedes mosquitoes for preventing dengue infection.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Trial
  3. Overview of Chikungunya Virus Epidemiology, Biology, and Pathogenesis.Methods in molecular biology (Clifton, N.J.) · 2027
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Research Trends and Collaborative Patterns inInternational journal of environmental research and public health · 2026
    Article
  11. Article
  12. Review
  13. Strategies forOne health (Amsterdam, Netherlands) · 2026
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. The impact of large-scale release ofLancet regional health. Americas · 2026
    Article

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 4 countries.

Sofia B PintoWorld Mosquito Program, Fiocruz, Rio de Janeiro, Brazil.ORCID 0000-0001-7758-6706
Thais I S RibackWorld Mosquito Program, Fiocruz, Rio de Janeiro, Brazil.ORCID 0000-0001-7553-243X
Gabriel SylvestreWorld Mosquito Program, Fiocruz, Rio de Janeiro, Brazil.
Guilherme CostaWorld Mosquito Program, Fiocruz, Rio de Janeiro, Brazil.
Julia PeixotoWorld Mosquito Program, Fiocruz, Rio de Janeiro, Brazil.ORCID 0000-0002-8195-6666
Fernando B S DiasWorld Mosquito Program, Fiocruz, Rio de Janeiro, Brazil.
Stephanie K TanamasWorld Mosquito Program, Institute of Vector Borne Disease, Monash University, Clayton, Australia.
Cameron P SimmonsWorld Mosquito Program, Institute of Vector Borne Disease, Monash University, Clayton, Australia.
Suzanne M DufaultDivision of Biostatistics, School of Public Health, University of California, Berkeley, California, United States of America.ORCID 0000-0002-6316-6548
Peter A RyanWorld Mosquito Program, Institute of Vector Borne Disease, Monash University, Clayton, Australia.ORCID 0000-0003-0674-4441
Scott L O'NeillWorld Mosquito Program, Institute of Vector Borne Disease, Monash University, Clayton, Australia.ORCID 0000-0002-4131-3615
Frederico C MuzziWorld Mosquito Program, Institute of Vector Borne Disease, Monash University, Clayton, Australia.
Simon KutcherWorld Mosquito Program, Institute of Vector Borne Disease, Monash University, Clayton, Australia.ORCID 0000-0002-5297-4435
Jacqui MontgomeryWorld Mosquito Program, Institute of Vector Borne Disease, Monash University, Clayton, Australia.ORCID 0000-0003-3404-9024
Benjamin R GreenWorld Mosquito Program, Institute of Vector Borne Disease, Monash University, Clayton, Australia.
Ruth SmithymanWorld Mosquito Program, Institute of Vector Borne Disease, Monash University, Clayton, Australia.
Ana EppinghausCity Health Secretariat, Niteroi, Brazil.
Valeria SaraceniCity Health Secretariat, Rio de Janeiro, Brazil.ORCID 0000-0001-7360-6490
Betina DurovniWorld Mosquito Program, Fiocruz, Rio de Janeiro, Brazil.
Katherine L AndersWorld Mosquito Program, Institute of Vector Borne Disease, Monash University, Clayton, Australia.ORCID 0000-0003-0485-5826
Luciano A MoreiraWorld Mosquito Program, Fiocruz, Rio de Janeiro, Brazil.
Monash University · AUFundação Oswaldo Cruz · BRMinistério da Saúde · BROxford University Clinical Research Unit · VNUniversity of California, Berkeley · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe introduction of the bacterium Wolbachia (wMel strain) into Aedes aegypti mosquitoes reduces their capacity to transmit dengue and other arboviruses. Evidence of a reduction in dengue case incidence following field releases of wMel-infected Ae. aegypti has been reported previously from a cluster randomised controlled trial in Indonesia, and quasi-experimental studies in Indonesia and northern Australia. METHODOLOGY/PRINCIPAL

findingsFollowing pilot releases in 2015-2016 and a period of intensive community engagement, deployments of adult wMel-infected Ae. aegypti mosquitoes were conducted in Niterói, Brazil during 2017-2019. Deployments were phased across four release zones, with a total area of 83 km2 and a residential population of approximately 373,000. A quasi-experimental design was used to evaluate the effectiveness of wMel deployments in reducing dengue, chikungunya and Zika incidence. An untreated control zone was pre-defined, which was comparable to the intervention area in historical dengue trends. The wMel intervention effect was estimated by controlled interrupted time series analysis of monthly dengue, chikungunya and Zika case notifications to the public health surveillance system before, during and after releases, from release zones and the control zone. Three years after commencement of releases, wMel introgression into local Ae. aegypti populations was heterogeneous throughout Niterói, reaching a high prevalence (>80%) in the earliest release zone, and more moderate levels (prevalence 40-70%) elsewhere. Despite this spatial heterogeneity in entomological outcomes, the wMel intervention was associated with a 69% reduction in dengue incidence (95% confidence interval 54%, 79%), a 56% reduction in chikungunya incidence (95%CI 16%, 77%) and a 37% reduction in Zika incidence (95%CI 1%, 60%), in the aggregate release area compared with the pre-defined control area. This significant intervention effect on dengue was replicated across all four release zones, and in three of four zones for chikungunya, though not in individual release zones for Zika. CONCLUSIONS/SIGNIFICANCE: We demonstrate that wMel Wolbachia can be successfully introgressed into Ae. aegypti populations in a large and complex urban setting, and that a significant public health benefit from reduced incidence of Aedes-borne disease accrues even where the prevalence of wMel in local mosquito populations is moderate and spatially heterogeneous. These findings are consistent with the results of randomised and non-randomised field trials in Indonesia and northern Australia, and are supportive of the Wolbachia biocontrol method as a multivalent intervention against dengue, chikungunya and Zika.

Indexed as

AedesAnimalsBrazilChikungunya FeverChikungunya virusDengueDengue VirusFemaleHumansIncidenceMaleMosquito ControlMosquito VectorsWolbachiaZika VirusZika Virus Infection

Identifiers

PMID34252106
PMCPMC8297942
OpenAlexW3178766860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.